Back to BlackRock Finance, Inc. BlackRock Finance, Inc.

CERECERE
3 quarters

Position history for BlackRock Finance, Inc.BlackRock Finance, Inc.'s holdings in CEREVEL THERAPEUTICS HLDNG I

BlackRock Finance, Inc. holds 3.6M shares of CERE (CEREVEL THERAPEUTICS HLDNG I), worth $145.6M as of 2024-Q2. The position was decreased (-34.6% shares). CERE represents 0.0% of BlackRock Finance, Inc.'s portfolio.

Current Value

$145.6M

Current Shares

3.6M

Total Value Change

-$110M

Total Shares Change

-2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Decreased
3.6M
-34.6%
$145.6M0.0%
0
2024-Q1
Decreased
5.4M
-9.6%
$230.3M0.0%
0
2023-Q4
New
6M
-
$255.6M0.0%
43

Other major holders of CERE: Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used